IDEXX enters $1B revolving credit facility with extended maturity and lower rates

IDEXX LABORATORIES INC /DE

Fourth amended & restated credit agreement provides $1B unsecured revolver with $250M accordion feature.
Maturity extended to December 9, 2026 (from 2020 agreement's 3-year term).
Interest rate margins reduced; pricing (LIBOR + 0.875–1.375%) based on consolidated leverage ratio.
New borrowers added: IDEXX Laboratories B.V. (Netherlands) and IDEXX Laboratories GmbH (Switzerland).
Proceeds for general corporate purposes; commitment fee on unused portion ranges 0.075–0.250%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.